Income Taxes (Details) - USD ($) $ in Thousands |
3 Months Ended | ||
|---|---|---|---|
May 31, 2025 |
May 31, 2024 |
Feb. 28, 2025 |
|
| Effective Income Tax Rate Reconciliation [Line Items] | |||
| Transitional income tax benefit due to reorganization | $ 64,600 | ||
| Asset impairment charges | $ 414,385 | $ 0 | |
| Nondeductible goodwill impairment loss | 265,000 | ||
| Tax benefit related to the asset impairment charge | 24,200 | ||
| Deferred tax assets, valuation allowance | 16,500 | ||
| Income tax expense | $ 30,180 | 12,116 | |
| Foreign Tax Authority | Barbados Revenue Authority | |||
| Effective Income Tax Rate Reconciliation [Line Items] | |||
| Discrete tax charge due to change in legislation | $ 6,000 | ||
| X | ||||||||||
- Definition Effective Income Tax Rate Reconciliation, Intangible Asset Reorganization, Amount No definition available.
|
| X | ||||||||||
- Definition Income Tax Expense (Benefit), Goodwill Impairment Loss No definition available.
|
| X | ||||||||||
- Definition Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible impairment loss. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|